Skip to main content
. 2020 Mar 5;12(3):229. doi: 10.3390/pharmaceutics12030229

Figure 2.

Figure 2

Identified subcategories of prerequisites for the adoption of 3D-printed drug products for pediatric patients at hospital wards.